Home Medicine The weighting factor of exponentially weighted moving average chart
Article Publicly Available

The weighting factor of exponentially weighted moving average chart

  • Hikmet Can Çubukçu ORCID logo EMAIL logo
Published/Copyright: September 18, 2020

To the Editor,

The exponentially weighted moving average (EWMA), firstly described by Roberts in 1959, is known to be beneficial for determining small shifts in the quality control process [1]. Therefore, it can help laboratorians to take preventive action before the process gets out of control.

Exponentially weighted moving average (EWMA) chart can be drawn by the following formula [2]:

zi=λ×xi+(1 λ)×zi1
  • xi: Current result

  • zi: ith EWMA result

  • zi−1: (i − 1)th EWMA result

  • λ: The weighting factor which determines the weight to be given to the current and previous quality control results.

  • Upper and lower control limits are calculated by following formulas [2]:

    Uppercontrollimit(UCL) = μ+Lσ((λ)(1(1 λ)(2i))(2 λ)
    Lowercontrollimit(LCL)= μLσ((λ)(1(1 λ)(2i))(2 λ)
  • μ=z0: Target value

  • σ: Standard deviation

  • L: The factor determines the width of upper and lower control limits.

When the value of zi exceeds control limits, the process is considered out of control.

The weighting factor (λ) represents the most crucial part of the EWMA chart. EWMA chart was found to be superior to the Shewart chart for detecting small shifts in mean and variance when a small weighting factor is used (especially lower than 0.20) [3].

Weighting factor takes a value between 0 and 1. When the weighting factor is chosen as 1, the EWMA chart turns into the Shewart chart [4]. Different approaches have been described in the literature about the utility of the weighting factor. Small weighting factors (0,05–0,20) are preferred for determining small shifts that comply with fitness for the purpose [3]. However, this approach can’t quickly respond to a sudden large reverse shift due to the inertia effect. Thus, the Shewart chart should be used along with the EWMA chart when a small weighting factor is selected [5]. Linnet stated that weighting factor 0.5 could be more suitable for detecting larger shifts as 2 s encountered in daily laboratory practice. This approach performs better than traditional quality control rules, as indicated previously [6].

Another approach described by Neubauer is based on determining the weighting factor by adjusting shift sensitivity. Firstly, the most sensitive shift is determined using designated critical error (shift) which can be calculated by the following formulas [4], [7]:

criticalerror(shift) = totalerrorbiasstandarddeviation1.65

or

criticalerror(shift)=totalerror%  bias%coefficientofvariation%1.65

or

criticalerror(shift) = sigmametricvalue  1.65

The critical shift corresponds to the most sensitive shift.

Secondly, the corresponding weighting factor is chosen from the chart offered by Neubauer, as shown in Figure 1 [4]. For example, the allowable total error of albumin is 8%, according to Clinical Laboratory Improvement Amendments 2019 criteria. If the bias is 1% and analytical coefficient of variation is 1.24%, the critical error becomes 4% ((8 − 1)/1.24) − 1.65 = 4. In this case, the corresponding weighting factor is 0.9. When the EWMA chart with the weighting factor “0.1” applied to 1% positively biased simulation results, the first out of control result detected in the 30th day, as shown in Figure 2. However, when the weighting factor “0.9” preferred, there was no out of control result detected, as shown in Figure 3.

Figure 1: Optimal weighting factor corresponding to the shift according to Neubauer [4].
Figure 1:

Optimal weighting factor corresponding to the shift according to Neubauer [4].

Figure 2: EWMA chart with weighting factor = 0.1 applied to 1% positively biased simulation results.
Figure 2:

EWMA chart with weighting factor = 0.1 applied to 1% positively biased simulation results.

Figure 3: EWMA chart with weighting factor = 0.9 applied to 1% positively biased simulation results.
Figure 3:

EWMA chart with weighting factor = 0.9 applied to 1% positively biased simulation results.

This high weighting factor hinders EWMA’s efficiency in detecting small systematic shifts. Therefore in this problematic approach, high sigma metric values will lead to the selection of high lambda values. The power of the EWMA chart to detect small shifts will decrease, which is not fit for the purpose.

Hence, the utility of critical error to determine the weighting factor seems to be unreasonable. The most sensible approach might be choosing a low weighting factor for the EWMA chart to work in fitness for the purpose and the usage of it in combination with the Shewart chart. Simulation studies about EWMA should be carried out to determine optimum weighting factors.


Corresponding author: Hikmet Can Çubukçu M.D, Department of Medical Biochemistry, Erzurum Maresal Cakmak State Hospital, Erzurum, Turkey. Phone: +905376728807, E-mail:

References

1. Lucas, JM, Saccucci, MS. Exponentially weighted moving average control schemes: properties and enhancements. Technometrics 1990;32:1–12. https://doi.org/10.1080/00401706.1990.10484583.Search in Google Scholar

2. Montgomery, DC. Statistical quality control, 7th ed. Wiley; 2012.Search in Google Scholar

3. Carson, PK, Yeh, AB. Exponentially weighted moving average (EWMA) control charts for monitoring an analytical process. Ind Eng Chem Res 2008;47:405–11. https://doi.org/10.1021/ie070589b.Search in Google Scholar

4. Neubauer, AS. The EWMA control chart: properties and comparison with other quality-control procedures by computer simulation. Clin Chem 1997;43:594–601. https://doi.org/10.1093/clinchem/43.4.594.Search in Google Scholar

5. Woodall, WH, Mahmoud, MA. The inertial properties of quality control charts. Technometrics 2005;47:425–36. https://doi.org/10.1198/004017005000000256.Search in Google Scholar

6. Linnet, K. The exponentially weighted moving average (EWMA) rule compared with traditionally used quality control rules. Clin Chem Lab Med 2006;44:396–9. https://doi.org/10.1515/cclm.2006.077.Search in Google Scholar PubMed

7. Westgard, JO. Useful measures and models for analytical quality management in medical laboratories. Clin Chem Lab Med 2016;54:223–33. https://doi.org/10.1515/cclm-2015-0710.Search in Google Scholar PubMed

Received: 2019-09-04
Accepted: 2020-02-14
Published Online: 2020-09-18

© 2020 Walter de Gruyter GmbH, Berlin/Boston

Articles in the same Issue

  1. Frontmatter
  2. Review Article
  3. Newly developed diagnostic methods for SARS-CoV-2 detection
  4. Short Communication
  5. Effect of hemolysis on prealbumin assay
  6. Research Articles
  7. BioVar: an online biological variation analysis tool
  8. High dose ascorbic acid treatment in COVID-19 patients raised some problems in clinical chemistry testing
  9. Immunoassay biomarkers of first and second trimesters: a comparison between pregnant Syrian refugees and Turkish women
  10. Association of maternal serum trace elements with newborn screening-thyroid stimulating hormone
  11. PIK3CA and TP53 MUTATIONS and SALL4, PTEN and PIK3R1 GENE EXPRESSION LEVELS in BREAST CANCER
  12. Evaluation of E2F3 and survivin expression in peripheral blood as potential diagnostic markers of prostate cancer
  13. Age, gender and season dependent 25(OH)D levels in children and adults living in Istanbul
  14. Original Article
  15. Fractional excretion of magnesium as an early indicator of renal tubular damage in normotensive diabetic nephropathy
  16. Research Articles
  17. Diagnostic value of laboratory results in children with acute appendicitis
  18. Evaluation of thiol disulphide levels in patients with pulmonary embolism
  19. Relationship between renal tubulointerstitial fibrosis and serum prolidase enzyme activity
  20. Comparison of test results obtained from lithium heparin gel tubes and serum gel tubes
  21. MHC Class I related chain A (MICA), Human Leukocyte Antigen (HLA)-DRB1, HLA-DQB1 genotypes in Turkish patients with ulcerative colitis
  22. An overview of procalcitonin in Crimean-Congo hemorrhagic fever: clinical diagnosis, follow-up, prognosis and survival rates
  23. Comparison of different equations for estimation of low-density lipoprotein (LDL) – cholesterol
  24. Case-Report
  25. A rare case of fructose-1,6-bisphosphatase deficiency: a delayed diagnosis story
  26. Research Articles
  27. Atypical cells in sysmex UN automated urine particle analyzer: a case report and pitfalls for future studies
  28. Investigation of the relationship cellular and physiological degeneration in the mandible with AQP1 and AQP3 membrane proteins
  29. In vitro assessment of food-derived-glucose bioaccessibility and bioavailability in bicameral cell culture system
  30. Letter to the Editor
  31. The weighting factor of exponentially weighted moving average chart
Downloaded on 5.12.2025 from https://www.degruyterbrill.com/document/doi/10.1515/tjb-2019-0368/html
Scroll to top button